BOSTON — In this Healio Video Perspective from the ASCRS meeting, Cody McKenzie of Glaukos discusses the anticipated impact of the iDose TR, which launched during the meeting.He also announced that the travoprost intracameral implant, indicated for the…
Author: Healio ophthalmology
Progress has been slow in stem cell therapy for retinal diseases
BOSTON — Stem cell therapies for retinal diseases come with advantages and disadvantages, according to a speaker at the American Society of Cataract and Refractive Surgery meeting.Rajesh C. Rao, MD, ABO, said stem cells therapy has gotten a lot of atte…
VIDEO: Teneo excimer laser offers fast ablation, advanced eye tracking
BOSTON — In this Healio Video Perspective from Eyecelerator@ASCRS, Anthony Wallace of Bausch + Lomb discusses company updates, including the recent FDA approval of the Teneo excimer laser.“Teneo is the first excimer laser approved in the U.S. in nearly…
VIDEO: Nordic Pharma Eye Care prepares for Lacrifill launch at ASCRS
BOSTON — In this Healio Video Perspective from Eyecelerator@ASCRS, Nordic Pharma Eye Care U.S. president Philip Gioia and chief commercial officer Jai G. Parekh, MD, MBA, FAAO, discuss the launch of Lacrifill for dry eye disease.Gioia said the company’…
VIDEO: Improved cross-linking techniques on the horizon
BOSTON — In this Healio Video Perspective from the ASCRS meeting, Michael B. Raizman, MD, ABO, discusses the future of corneal cross-linking.Raizman said there are advancements in technique on the way, with the potential to provide better treatment for…
Lens exchange is next wave of refractive surgery
BOSTON — Refractive lens exchange technology has reached the point where patients are taking notice, making it the latest wave in refractive surgery, according to a speaker here.In the Steinert Lecture at Refractive Day at the American Society of Catar…
VIDEO: Femtosecond laser-assisted cataract surgery shows benefits over manual surgery
BOSTON — In this Healio Video Perspective from the ASCRS meeting, Robert J. Weinstock, MD, discusses a study on femtosecond laser-assisted cataract surgery.The study compared cataract surgery with manual phacoemulsification and femtosecond laser-assist…
Yearly exams critical to identify keratoconus progression, even after cross-linking
BOSTON — Annual exams with topography are key to identifying progression in patients with keratoconus regardless of whether they have undergone cross-linking, according to a speaker here.At Cornea Day at the American Society of Cataract and Refractive …
Woman experiences previous ‘gush’ of fluid from right eye, now acute left eye pain
A 28-year-old Latino woman presented to the University of New Mexico emergency department with the complaint of acute onset left eye pain, photophobia and visual decline.She described the pain as sharp and constant with a severity of 7 out of 10. Her s…
Twenty-one hallmarks to professionalize you and your practice
“If you think it’s expensive to hire a professional to do the job, wait until you hire an amateur.” – Red Adair“I recently went to a new doctor and noticed he was located in something called the professional building. I felt better right away.” – Georg…
Ophthalmologists should pursue balanced lifestyle in face of professional dissatisfaction
I find the annual surveys on physician compensation, lifestyle/happiness and burnout/depression, published by Medscape, to be informative. In the following paragraphs, I will share some of these findings and my perspective.The Medscape findings are rel…
Ophthalmologists aware of need to protect mental, physical health
Ophthalmology is typically seen as one of the most rewarding careers in medicine.It is a thriving field that offers the excitement of continuous innovation, a high degree of patient satisfaction, more autonomy and more controllable working schedules as…
How do you deal with stress related to patient complications?
Click here to read the Cover Story, “Ophthalmologists aware of need to protect mental, physical health.”Fortunately, I am a surgeon who has not had a high rate of complications, but nobody’s rate is zero. I have vivid memories of the moment when I rupt…
Case report: Live worm found in patient’s eye
Ocular parasitosis consistently perplexes ophthalmologists due to its varied and unpredictable presentations. The elusive nature of the disease ensures it remains concealed unless actively sought out through diligent examination.Gnathostomiasis is a ra…
Case report: Cryopreserved amniotic membrane used for glaucoma medication-induced dry eye
More than half of all patients treated with glaucoma medications have ocular surface disease, which predominantly manifests as dry eye disease.Glaucoma treatment has been associated with higher levels of ocular surface alterations and inflammatory mark…
VIDEO: Aurion aims to end corneal endothelial disease with cell therapy
BOSTON — In this Healio Video Perspective from Eyecelerator@ASCRS, Greg Kunst, CEO of Aurion Biotech, discusses the company’s cell therapy for corneal endothelial disease.Kunst said the company is nearing completion of its phase 1/2 trial, and recent d…
VIDEO: ViaLase platform combines femtosecond laser, OCT for glaucoma treatment
BOSTON — In this Healio Video Perspective from Eyecelerator@ASCRS, Pete England, vice president of global marketing at ViaLase, discusses the company’s femtosecond laser platform for the treatment of open-angle glaucoma.England said it is the first tim…
New technology, product launches drive excitement in ophthalmology
BOSTON — Despite the unpredictability that comes with new product launches and reimbursement issues, experts are hopeful about ophthalmic business prospects in 2024.“It is an election year, and that comes with its own uncertainty. I’m sure my colleague…
Melt Pharmaceuticals closes $24 million in Series B financing
Melt Pharmaceuticals secured $24 million in Series B preferred stock financing from new and existing investors, according to a press release.The funds will be used to advance the development of MELT-300, a non-IV, nonopioid tablet for procedural sedati…
Lenz presbyopia drop meets endpoints in near vision improvement in phase 3 trials
Patients with presbyopia achieved visual acuity improvement with LNZ100 in the phase 3 CLARITY safety and efficacy trials, according to a press release from Lenz Therapeutics.The CLARITY 1 and 2 trials investigated the eye drops LNZ100 (1.75% aceclidin…